Loading...

SOHO 2026 Annual Meeting

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Poster Session

Thumbnail for Preclinical Evaluation of INCA035784, a Novel T-Cell-Redirecting Antibody for the Treatment of MutCALR-Driven Myeloproliferative Neoplasms (MPNs)

MPN - 553

Preclinical Evaluation of INCA035784, a Novel T-Cell-Redirecting Antibody for the Treatment of MutCALR-Driven Myeloproliferative Neoplasms (MPNs)

Liang-Chuan Wang

Poster Presenter: Liang-Chuan Wang

Thumbnail for Mutant Calreticulin-Specific Monoclonal Antibody, INCA033989, Is Well Tolerated and Achieves Robust Spleen, Anemia, and Molecular Responses in Patients With Myelofibrosis

MPN - 554

Mutant Calreticulin-Specific Monoclonal Antibody, INCA033989, Is Well Tolerated and Achieves Robust Spleen, Anemia, and Molecular Responses in Patients With Myelofibrosis

Tania Jain

Poster Presenter: Tania Jain

Thumbnail for Trial in Progress: A Phase 3, Randomized, Double-Blind, Active-Control Study of Pelabresib (DAK539) Plus Ruxolitinib vs Placebo Plus Ruxolitinib in JAK Inhibitor-Naive Adult Patients With Myelofibrosis (MANIFEST-3)

MPN - 555

Trial in Progress: A Phase 3, Randomized, Double-Blind, Active-Control Study of Pelabresib (DAK539) Plus Ruxolitinib vs Placebo Plus Ruxolitinib in JAK Inhibitor-Naive Adult Patients With Myelofibrosis (MANIFEST-3)

John Mascarenhas

Poster Presenter: John Mascarenhas

Thumbnail for Mutant Calreticulin-Specific Monoclonal Antibody INCA033989 Produces Molecular Responses That Correlate With Clinical Responses in Patients With Myelofibrosis

MPN - 556

Mutant Calreticulin-Specific Monoclonal Antibody INCA033989 Produces Molecular Responses That Correlate With Clinical Responses in Patients With Myelofibrosis

John Mascarenhas

Poster Presenter: John Mascarenhas

Thumbnail for Healthcare Provider Perspectives on the Therapeutic Phlebotomy Workflow in Polycythemia Vera and Associated Resource Use in the United States

MPN - 558

Healthcare Provider Perspectives on the Therapeutic Phlebotomy Workflow in Polycythemia Vera and Associated Resource Use in the United States

Naveen Pemmaraju

Poster Presenter: Naveen Pemmaraju

Thumbnail for Real-World Treatment Patterns and Outcomes in Patients With Myelofibrosis Treated With First-Line Pacritinib or Ruxolitinib

MPN - 564

Real-World Treatment Patterns and Outcomes in Patients With Myelofibrosis Treated With First-Line Pacritinib or Ruxolitinib

Naveen Pemmaraju

Poster Presenter: Naveen Pemmaraju

Thumbnail for Machine Learning-Based Model for Renal Replacement Therapy Risk Stratification in Tumor Lysis Syndrome: Development and External Validation Across MIMIC-IV and eICU Cohorts

MPN - 571

Machine Learning-Based Model for Renal Replacement Therapy Risk Stratification in Tumor Lysis Syndrome: Development and External Validation Across MIMIC-IV and eICU Cohorts

Anmol Kumar

Poster Presenter: Anmol Kumar

Thumbnail for Real-World Phlebotomy (PHL) Burden and Treatment Gaps in US Patients with Polycythemia Vera (PV): A Chart Review Across Physician Practice Settings

MPN - 572

Real-World Phlebotomy (PHL) Burden and Treatment Gaps in US Patients with Polycythemia Vera (PV): A Chart Review Across Physician Practice Settings

Andrew Srisuwananukorn

Poster Presenter: Andrew Srisuwananukorn

Thumbnail for Mutational Landscape and Hematological Correlations in Myeloproliferative Neoplasms: A 5-Year Retrospective Study from a Lebanese Tertiary Center

MPN - 586

Mutational Landscape and Hematological Correlations in Myeloproliferative Neoplasms: A 5-Year Retrospective Study from a Lebanese Tertiary Center

Sarah Gerges

Poster Presenter: Sarah Gerges